Zhang et al. [42] utilized a competitive receptor antagonist for TGF-β type I receptors to indicate that impaired TGF-β signaling might generate an imbalance of Th17/Treg ratio in the peripheral blood of smokers, suggesting a potential factor for COPD development. The gene discussed is TGFB1; the disease is chronic obstructive pulmonary disease.